Brief: Rallybio Publishes Data Highlighting Ability Of HPA-1a-Specific Antibodies
Dec 15 (Reuters) - Rallybio Corp RLYB.O :
* RALLYBIO ANNOUNCES PUBLICATION OF DATA HIGHLIGHTING THE
ABILITY
OF HPA-1A-SPECIFIC ANTIBODIES TO PREVENT ALLOIMMUNIZATION IN AN
AUTHENTIC MOUSE MODEL OF FNAIT
* RALLYBIO - DATA DEMONSTRATES HPA-1A ALLOIMMUNIZATION CAN
BE
PREVENTED WITH PROPHYLACTIC ADMINISTRATION OF LOW LEVELS OF
HPA-1A-SPECIFIC ANTIBODIES
Source text for Eikon: ID:nBw2GL25Da
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx